A share price of Immunovant Inc [IMVT] is currently trading at $15.41, up 3.77%. In order to assess the stock’s recent performance, you can check whether its short-term value is rising or falling. The IMVT shares have gain 6.57% over the last week, with a monthly amount drifted -3.08%, and not seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
Immunovant Inc [NASDAQ: IMVT] stock has seen the most recent analyst activity on March 03, 2025, when Jefferies initiated its Hold rating and assigned the stock a price target of $20. Previously, Wolfe Research downgraded its rating to Peer Perform on January 03, 2025. Oppenheimer reiterated its Outperform rating and increased its price target to $53 on October 09, 2024. Oppenheimer initiated its recommendation with a Outperform and recommended $50 as its price target on March 28, 2024. Goldman started tracking with a Buy rating for this stock on March 13, 2024, and assigned it a price target of $50. In a note dated February 20, 2024, JP Morgan initiated an Overweight rating and provided a target price of $51 on this stock.
Immunovant Inc experienced fluctuations in its stock price throughout the past year between $12.72 and $34.47. Currently, Wall Street analysts expect the stock to reach $42.83 within the next 12 months. Immunovant Inc [NASDAQ: IMVT] shares were valued at $15.41 at the most recent close of the market. An investor can expect a potential return of 177.94% based on the average IMVT price forecast.
Analyzing the IMVT fundamentals
Upon thorough examination of the company’s fundamental financial framework, it becomes apparent that the debt-to-equity ratio stands at 0.0.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 14.83 points at the first support level, and at 14.25 for the second support level. However, for the 1st resistance point, the stock is sitting at 15.74, and for the 2nd resistance point, it is at 16.07.
Ratios To Look Out For
To put it in perspective, the Current Ratio for Immunovant Inc [NASDAQ:IMVT] is 11.16. In addition, the Quick Ratio stands at 11.16 and the Cash Ratio stands at 10.38.
Transactions by insiders
Recent insider trading involved GEORGE V MIGAUSKY, Former Director, that happened on May 21 ’25 when 21812.0 shares were purchased. Former Director, GEORGE V MIGAUSKY completed a deal on May 19 ’25 to buy 28188.0 shares. Meanwhile, Chief Technology Officer Stout Jay S sold 1925.0 shares on Apr 23 ’25.
